Gossamer Bio (GOSS) Stock Fair Value Moves Lower After Mixed Analyst Target Changes

Gossamer Bio is back in focus after its fair value estimate was trimmed from $4.46 to $3.86, a shift that has caught the ...
Yahoo Finance

Why Analysts Say Gossamer Bio’s Story Is Changing Ahead of Critical Clinical Milestones

Gossamer Bio's consensus analyst price target has recently risen from $8.86 to $9.50, which signals a more optimistic outlook among market observers. This adjustment comes as analyst sentiment grows ...
Live for the Outdoors on MSN

Gossamer Gear G4-20 ultralight 42 backpack review: The perfect pack for weight-conscious hikers?

If you pack light and want to keep weight down on multi-day hikes, the Gossamer Gear G4-20 Ultralight 42 Backpack may be for ...
Yahoo Finance

How The Investment Story For Gossamer Bio (GOSS) Is Quietly Shifting Without New Analyst Signals

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Gossamer Bio’s latest analyst update comes with no change to ...
Business Wire

CLASS ACTION DEADLINE TONIGHT: Gossamer Bio (GOSS) Investors Who Suffered Losses Encouraged to Contact Faruqi & Faruqi Before June 1, 2026 Securities Class Action Deadline

NEW YORK--(BUSINESS WIRE)--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Gossamer Bio, Inc. (“Gossamer” or the “Company”) (NASDAQ: GOSS) and ...